Canada - English - Health Canada

pfizer canada ulc - oxaliplatin - solution - 5mg - oxaliplatin 5mg - antineoplastic agents

Canada - English - Health Canada

sterimax inc - metoprolol tartrate - solution - 1mg - metoprolol tartrate 1mg - beta-adrenergic blocking agents

Canada - English - Health Canada

janssen inc - daratumumab - solution - 100mg - daratumumab 100mg - antineoplastic agents

Canada - English - Health Canada

janssen inc - daratumumab - solution - 400mg - daratumumab 400mg - antineoplastic agents

Canada - English - Health Canada

fresenius kabi canada ltd - oxaliplatin - solution - 5mg - oxaliplatin 5mg - antineoplastic agents

Canada - English - Health Canada

dr reddy's laboratories ltd - oxaliplatin - solution - 5mg - oxaliplatin 5mg - antineoplastic agents

Canada - English - Health Canada

sterimax inc - levofloxacin - solution - 5mg - levofloxacin 5mg - quinolones

Canada - English - Health Canada

cubist pharmaceuticals llc - daptomycin - powder for solution - 500mg - daptomycin 500mg - cyclic lipopeptides

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - taliglucerase alfa 200 u (200 u deliverable, plus 6% overage) - powder for injection - 200 u - active: taliglucerase alfa 200 u (200 u deliverable, plus 6% overage) excipient: citric acid mannitol polysorbate 80 sodium citrate dihydrate - elelyso is indicated for long-term enzyme replacement therapy for adult and paediatric patients with a confirmed diagnosis of type 1 gaucher disease associated with at least one of the following: splenomegaly, hepatomegaly, anaemia, thrombocytopenia.

Canada - English - Health Canada

united therapeutics corporation - dinutuximab - solution - 3.5mg - dinutuximab 3.5mg - antineoplastic agents